sv se
nyhetsbrev2

Newsletter

Sign up for our newsletter
Partnering information




Gedea Biotech partnering information
Download Partnering information
 >
Gedea Biotech was on thursday evening crowned as winner of Game Changer award in Venture Cup competition Startup in Malmö. A Game Changer is an innovative startups with Potential to disrupt a current industry and the competitors were the 12 finalists chosen among close to 400 contributions. The prize was 50 000 SEK as well as gift cards from the Venture cup partnering organizations. On September 21st, the national finals in Lund awaits Gedea Biotech. Venture Cup is the competition of entrepreneurs of tomorrow, held every year since 1998.

http://www.venturecup.se/newsroom/#/pressreleases/haer-aer-vinnarna-av-venture-cup-syd-2017-1967836
http://www.innovation.lu.se/article/portfoljbolaget-gedea-biotech-vinnare-i-venture-cup
https://www.va.se/nyheter/2017/05/19/har-ar-sveriges-15-hetaste-startups--som-du-annu-inte-hort-talas-om/
http://www.medicinkollen.se/nyheter/har-ar-vinnarna-av-venture-cup-syd-2017/
https://www.8till5.se/2017-05-18/klocka-som-forebygger-fallolyckor-vinnare-i-venture-cup
Gedea Biotech has been selected as one of the 12 regional finalists in Venture Cup South among close to 400 contributions. Venture Cup is the competition of entrepreneurs of tomorrow, held every year since 1998. The participating teams compete in four categories: Student Superstart, Top Tech, Game Changer and Impact Maker. The regional final in Venture Cup South will be held in Malmö on May 18th and the winners will advance to the national finals on September 21st.

http://www.venturecup.se/newsroom/#/pressreleases/starkt-startfaelt-i-aarets-venture-cup-haer-aer-de-12-regionala-finalisterna-1947443
https://www.8till5.se/2017-05-04/tolv-regionala-bidrag-gor-upp-i-entreprenorstavlingen-venture-cup
http://www.breakit.se/artikel/7501/stor-lista-har-ar-alla-nominerade-i-venture-cups-startuptavling
http://www.kemivarldenbiotech.se/nyheter/gedea-biotech-till-final/

Gedea Biotech has been selected as one of the shortlisted entrants for the Emerging Technologies Competition, a European competition organized by the Royal Society of Chemistry in collaboration with industrial partners such as AstraZeneca, Pfizer and GE Healthcare. As one of the finalists, Gedea Biotech will present the company at the Chemistry Means Business Conference in Manchester, 13-14 June, where the prize-winners will be designated. Emerging Technologies Competition is arranged for the fifth consecutive year and aims to accelerate the commercialization of innovative technologies. See more about the competition at http://www.rsc.org/competitions/emerging-technologies/shortlisted-entries-2017/#health
Things goes well for the newly started company Gedea Biotech AB. During the first months of this year, the company, which is still in an early stage, received nearly one million crowns in grants. Now awaits continued development and then clinical studies and the company expects to be able to have an efficient and safe treatment for vaginal fungal infections available on the market within a few years.
Gedea Biotech won first prize at Lund University and Sparbanksstiftelsen Finn's competition for future innovations. The award was presented at Lund University's annual Innovation kickoff. The contest was open to all students and employees at Lund University. 77 entries were received, and a few were selected to pitch in and be interviewed by a renowned jury - the competition was fierce.
http://www.innovation.lu.se/article/framtidens-innovationer-prisbelonade
https://www.sydsvenskan.se/2017-03-15/framtidens-innovatorer-prisbelonade
http://www.kemivarldenbiotech.se/nyheter/pris-till-framtidens-innovationer/
Vinnova has granted Gedea Biotech's application for innovative startup companies. The applications were reviewed by external assessors and Gedea Biotech was one of the selected among over 650 applicants. Gedea Biotech develops a novel treatment of vaginal candida infections. In the project a prototype of the vaginal tablet will be formulated.
Read more
Three-quarters of all women suffer at some time of fungal infections in the genital area, which gives physical discomfort in the short term but is also likely to cause chronic problems. Now a research team at Lund University have found a naturally occurring substance, which in test tube studies have shown promising results against the right fungi. The university's holding company becomes a shareholder in a new company to bring the treatment to market
http://www.innovation.lu.se/article/lu-holding-investerar-i-ny-behandling-for-vanliga-kvinnobesvar
Article written by Rapidus: http://www.rapidus.se/lu-holding-investerar-i-innovation-mot-underlivsbesvar/
Article written by Näringsliv: http://www.naringsliv.se/tidningar/2017-1/life-science/life-science/innovation-facilitates-regional-growth/
kartaGedea Biotech AB
Medicon Village
Scheelevägen 2
223 81 Lund
Sweden
Annette Säfholm, CEO
annette.safholm@gedeabiotech.com
+46 (0) 708 - 91 86 81
nyhetsbrev
Eit